Monosaccharide Supplementation for Healthy Adults
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assess how a dietary supplement made of simple sugars (monosaccharides) affects the immune system, particularly antibody production in healthy adults. Participants will take one of three different supplements, including Monosaccharide Powder, or a placebo for comparison. This trial suits healthy adults not on any medication or supplement regimens and who maintain a balanced diet without extreme habits like excessive caffeine or alcohol consumption. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the opportunity to be among the first to receive this new supplement.
Will I have to stop taking my current medications?
Yes, you will need to stop taking any prescription or over-the-counter medications, as well as most supplements, to participate in this trial.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Studies have shown that monosaccharides, or simple sugars, are generally well-tolerated by the body. These sugars naturally occur in many foods and serve as the basic building blocks for more complex carbohydrates.
In this trial, participants will take varying amounts of monosaccharide supplements. Although specific safety data for these exact supplements is not yet available, research suggests that monosaccharides in food are likely safe.
This is a phase 1 trial, focusing primarily on safety. In phase 1, treatments are administered to a small group of people to ensure they do not cause serious side effects. Reaching this phase typically indicates that earlier lab or animal studies demonstrated sufficient safety for human testing.
In summary, monosaccharides are common in the diet, and this trial aims to confirm the safety of these supplements for people.12345Why are researchers excited about this trial's treatments?
Monosaccharide supplementation is unique because it explores the potential benefits of simple sugars in maintaining or improving health. Unlike standard supplements or dietary interventions, which often focus on complex carbohydrates or specific nutrients, these monosaccharide powders deliver straightforward energy sources that might enhance metabolic processes or gut health. Researchers are particularly excited about this approach because it could lead to quick improvements in energy levels and overall well-being without the need for complex dietary changes. Each experimental supplement has a different composition and dosage, offering insights into the optimal type and amount of monosaccharides that could deliver the most benefits.
What evidence suggests that this trial's treatments could be effective for immune system enhancement?
Research shows that monosaccharide supplements might affect the immune system in various ways. One study found a link between these supplements and improved diet quality, as well as a wider variety of gut bacteria, both crucial for health. A diverse range of gut bacteria can enhance immune function. Monosaccharides also aid in glycosylation, where sugars attach to proteins and fats, a process vital for many body functions, including immune response. Although direct evidence on the specific impact of these supplements on immune health is limited, these findings suggest the need for further research. This trial will evaluate different monosaccharide supplements, with participants receiving either one of the experimental supplements or a placebo comparator.678910
Who Is on the Research Team?
Emanual Maverakis
Principal Investigator
University of California, Davis
Are You a Good Fit for This Trial?
Healthy adults aged 18-45 with a BMI of 18.5-25 can join this trial. They shouldn't have taken any supplements except basic vitamins, or prescription meds in the last 3 months, and must not be on restrictive diets, consume lots of caffeine or alcohol, or have irregular menstrual cycles.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants consume dietary supplements or placebo daily for 4 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Long-term Follow-up
Further analysis of immune system effects through various assays
What Are the Treatments Tested in This Trial?
Interventions
- Monosaccharide Powder
- Placebo Comparator
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator